Aclaris Therapeutics Inc (ACRS)
1.11
-0.07
(-5.93%)
USD |
NASDAQ |
May 24, 16:00
1.15
+0.04
(+3.60%)
After-Hours: 20:00
Aclaris Therapeutics Market Cap: 79.10M for May 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 24, 2024 | 79.10M |
| May 23, 2024 | 84.09M |
| May 22, 2024 | 81.95M |
| May 21, 2024 | 84.09M |
| May 20, 2024 | 84.81M |
| May 17, 2024 | 84.81M |
| May 16, 2024 | 84.09M |
| May 15, 2024 | 84.09M |
| May 14, 2024 | 84.09M |
| May 13, 2024 | 84.09M |
| May 10, 2024 | 83.38M |
| May 09, 2024 | 87.30M |
| May 08, 2024 | 86.94M |
| May 07, 2024 | 95.49M |
| May 06, 2024 | 93.36M |
| May 03, 2024 | 96.92M |
| May 02, 2024 | 93.36M |
| May 01, 2024 | 89.79M |
| April 30, 2024 | 86.23M |
| April 29, 2024 | 86.94M |
| April 26, 2024 | 85.52M |
| April 25, 2024 | 84.81M |
| April 24, 2024 | 83.38M |
| April 23, 2024 | 86.94M |
| April 22, 2024 | 86.94M |
| Date | Value |
|---|---|
| April 19, 2024 | 88.37M |
| April 18, 2024 | 87.66M |
| April 17, 2024 | 87.66M |
| April 16, 2024 | 86.94M |
| April 15, 2024 | 86.21M |
| April 12, 2024 | 86.21M |
| April 11, 2024 | 86.92M |
| April 10, 2024 | 82.65M |
| April 09, 2024 | 84.79M |
| April 08, 2024 | 84.79M |
| April 05, 2024 | 84.79M |
| April 04, 2024 | 87.64M |
| April 03, 2024 | 89.06M |
| April 02, 2024 | 86.92M |
| April 01, 2024 | 89.77M |
| March 28, 2024 | 87.95M |
| March 27, 2024 | 89.37M |
| March 26, 2024 | 83.69M |
| March 25, 2024 | 82.27M |
| March 22, 2024 | 81.56M |
| March 21, 2024 | 85.11M |
| March 20, 2024 | 84.40M |
| March 19, 2024 | 81.56M |
| March 18, 2024 | 81.56M |
| March 15, 2024 | 82.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
31.15M
Minimum
Mar 18 2020
1.542B
Maximum
Apr 07 2021
550.57M
Average
557.66M
Median
May 12 2023
Market Cap Benchmarks
| Aldeyra Therapeutics Inc | 232.31M |
| CEL-SCI Corp | 66.62M |
| AIM ImmunoTech Inc | 19.74M |
| IGC Pharma Inc | 31.19M |
| NovaBay Pharmaceuticals Inc | 4.986M |
Market Cap Related Metrics
| PS Ratio | 2.527 |
| Price to Book Value | 0.557 |
| Price | 1.11 |
| Earnings Yield | -98.20% |